Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oral Health

Sec. Oral Infections and Microbes

This article is part of the Research TopicProbiotics and Bioactive Agents in Modulating Harmful Oral BiofilmsView all 11 articles

Effect of a bacterial Glutaminyl Cyclase inhibitor on multi-species-biofilms

Provisionally accepted
Sigrun  EickSigrun Eick1*Nadine  TaudteNadine Taudte2Daniel  RamsbeckDaniel Ramsbeck3,4Anna  MagdonAnna Magdon5Anton  SculeanAnton Sculean5Jan  PotempaJan Potempa6,7Mirko  BuchholzMirko Buchholz2
  • 1University of Bern, Bern, Switzerland
  • 2Perio Trap Pharmaceutical GmbH, Halle/Saale, Germany
  • 3Fraunhofer Institute for Cell Therapy and Immunology, Department of Molecular Drug Design and Target Validation, Halle/Saale, Germany
  • 4Hochschule Anhalt, Köthen, Germany
  • 5Universitat Bern, Bern, Switzerland
  • 6Department of Microbiology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
  • 7Department of Oral Immunology and Infectious Diseases, School of Dentistry, University of Louisville, Louisville, United States

The final, formatted version of the article will be published soon.

Modifying bacterial virulence could be an interesting alternative to antibiotics. The study aimed to examine the effects of an inhibitor targeting bacterial glutaminyl cyclase (which is selectively present in Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf), and Prevotella intermedia (Pi)) on various multispecies biofilms. Two multi-species biofilms—one containing four species (including Tf) and another with 12 species (including Tf, Pg, and Pi)—were cultured in the presence of 31.25–500 µM of a [4,5-c]pyridine-based inhibitor. After 24 hours, bacterial counts, biofilm biomass, metabolic activity, and, when Pg was included, Arg-gingipain activity were measured. Additionally, the biofilms were exposed to monocytic cells; here, the release of interleukin (IL)-1β and IL-10 was analyzed. The data were analyzed using a one-way analysis of variance (ANOVA) with a post-hoc comparison performed using the Bonferroni correction. In all biofilms, total bacterial counts and those of Pg and Tf remained unaffected by the inhibitor. In the 12-species biofilm, both 'biomass" and total metabolic activity decreased at high inhibitor concentrations (500 µM to 75.2 ± 6.5% and 87.2 ± 5.8%, respectively; each p < 0.001). The arginine-specific amidolytic activities of Rgp declined dose-dependently, down to 60.4 ± 10.2% (p<0.001) at 500 µM of the inhibitor. Consequently, Pg colonies lost 2 pigmentation as inhibitor concentrations increased. The inhibitor also reduced IL-1β release from monocytic cells stimulated by the 12-species biofilm. The studied [4,5-c]pyridine-based inhibitor is able to modify virulence of a multispecies biofilm. It might have the potential to be a promising approach in periodontal prevention and therapy.

Keywords: modifying bacterial virulence, Porphyromonas gingivalis, alternatives antibiotics, Biofilm modulation, Periodontitis

Received: 30 Sep 2025; Accepted: 06 Nov 2025.

Copyright: © 2025 Eick, Taudte, Ramsbeck, Magdon, Sculean, Potempa and Buchholz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Sigrun Eick, sigrun.eick@zmk.unibe.ch

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.